This listing may be outdated. Verify details at the official source before applying.

ActiveNational Library of Medicine (NLM) - National Institutes of Health (NIH) · 2026

NIH Academic Research Enhancement Awards (R15)

Quick Facts

Agency: National Library of Medicine (NLM) - National Institutes of Health (NIH)
Funding: Not specified
Deadline: Check Source
Status: Active
Eligibility: Undergraduate and/or graduate students and faculty in institutions of higher education that have not been major recipients of NIH research grant funds.

About This Grant

The NLM R15 program supports small research projects in NLM Scientific Areas of Interest conducted by undergraduate and/or graduate students and faculty. This program is for institutions of higher education that have not been major recipients of NIH research grant funds.

Locating official RFP…

Get a weekly digest of new grants like this

A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.

Or search similar grants →

Eligibility Requirements

Undergraduate and/or graduate students and faculty in institutions of higher education that have not been major recipients of NIH research grant funds.

Frequently Asked Questions

Who can apply for NIH Academic Research Enhancement Awards (R15)?

According to the current listing, eligibility includes: Undergraduate and/or graduate students and faculty in institutions of higher education that have not been major recipients of NIH research grant funds. Confirm the full requirements in the official notice before applying.

Who funds NIH Academic Research Enhancement Awards (R15)?

NIH Academic Research Enhancement Awards (R15) is funded by National Library of Medicine (NLM) - National Institutes of Health (NIH). Verify program details on the funder's official page before applying.

Competitive Intelligence

Past winners and funding trends for this program

Full analysis

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

Similar Grants from Other Funders

Dept. of the Army -- USAMRAA

Grants.govDeadline PassedBetween cycles — Between funding cycles - the FY26 required pre-application (LO…

DoW Duchenne Muscular Dystrophy, Idea Development Award

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Established Investigators.Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required for all applications. Clinical trials or clinical trial aims are not allowed. Funding Opportunity Number: HT942526DMDRPIDA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $2.5M total program funding.

Up to $500,000 total costs per award (2-year maximum)Deadline: Sep 4, 2026 (passed)

National Library of Medicine (NLM) - National Institutes of Health (NIH) Grant Writing Tips

NIH's National Library of Medicine Reopened the Clinical Informatics R01 (PAR-26-042) Through 2029, with $250K Direct Costs Per Year and a Narrow Responsiveness Window. The Next Deadline Is October 5 — and the Disqualification Criteria Are Where Most Applications Will Fail.

PAR-26-042 funds NLM-priority clinical informatics R01 grants up to $250,000 in direct costs per year through March 6, 2029, with standard NIH cycles on October 5, February 5, and June 5. The notice explicitly defines non-responsive applications: incremental tool improvements, projects primarily focused on social determinants of health, and projects primarily focused on ethical/legal/social issues. With NIH SBIR/STTR just reopened and the OMB Uniform Grants Regulation rewrite reshaping discretionary awards, the NLM clinical informatics line is one of the few stable, well-defined biomedical funding streams left at the agency. Here is how to read it.

Read article

NIH's PRIMED-AI: A Five-Part Common Fund Program to Turn Medical Imaging + Multimodal Data Into Clinical AI — Every RFA, Budget, and October 2026 Deadline

The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.

Read article

ARPA-H's Autism Program Staggered Its Deadlines Across Three Months. The Order Tells You What It Wants First.

ARPA-H launched SPECTRA on September 17, 2026 under solicitation ARPA-H-SOL-26-163 — four technical areas with separate Solution Summary deadlines on October 18, December 2, and January 18. The enabling-technologies area closes first, five weeks after launch. Here is why the sequencing matters and how to read each TA.

Read article